date: 2022-04-08T08:30:04Z pdf:PDFVersion: 1.6 pdf:docinfo:title: Responsivity of the Striatal Dopamine System to Methylphenidate?A Within-Subject I-123-?-CIT-SPECT Study in Male Children and Adolescents With Attention-Deficit/Hyperactivity Disorder xmp:CreatorTool: LaTeX with hyperref package + hypdvips access_permission:can_print_degraded: true subject: Background: Methylphenidate (MPH) is the first-line pharmacological treatment of attention-deficit/hyperactivity disorder (ADHD). language: en dc:format: application/pdf; version=1.6 pdf:docinfo:creator_tool: LaTeX with hyperref package + hypdvips access_permission:fill_in_form: true pdf:encrypted: false dc:title: Responsivity of the Striatal Dopamine System to Methylphenidate?A Within-Subject I-123-?-CIT-SPECT Study in Male Children and Adolescents With Attention-Deficit/Hyperactivity Disorder modified: 2022-04-08T08:30:04Z cp:subject: Background: Methylphenidate (MPH) is the first-line pharmacological treatment of attention-deficit/hyperactivity disorder (ADHD). pdf:docinfo:subject: Background: Methylphenidate (MPH) is the first-line pharmacological treatment of attention-deficit/hyperactivity disorder (ADHD). pdf:docinfo:creator: Hans-Christoph Aster and Lorenz Deserno meta:author: Hans-Christoph Aster and Lorenz Deserno meta:creation-date: 2022-04-08T03:56:38Z created: 2022-04-08T03:56:38Z access_permission:extract_for_accessibility: true Creation-Date: 2022-04-08T03:56:38Z Author: Hans-Christoph Aster and Lorenz Deserno producer: dvips + MiKTeX GPL Ghostscript 9.0 pdf:docinfo:producer: dvips + MiKTeX GPL Ghostscript 9.0 pdf:unmappedUnicodeCharsPerPage: 0 dc:description: Background: Methylphenidate (MPH) is the first-line pharmacological treatment of attention-deficit/hyperactivity disorder (ADHD). Keywords: methylphenidate, attention deficit/hyperactivity disorder (ADHD), striatum, single photon emission computed tomography (SPECT), responsivity, caudate nucleus, dopamine transporter (DAT) access_permission:modify_annotations: true dc:creator: Hans-Christoph Aster and Lorenz Deserno description: Background: Methylphenidate (MPH) is the first-line pharmacological treatment of attention-deficit/hyperactivity disorder (ADHD). dcterms:created: 2022-04-08T03:56:38Z Last-Modified: 2022-04-08T08:30:04Z dcterms:modified: 2022-04-08T08:30:04Z title: Responsivity of the Striatal Dopamine System to Methylphenidate?A Within-Subject I-123-?-CIT-SPECT Study in Male Children and Adolescents With Attention-Deficit/Hyperactivity Disorder xmpMM:DocumentID: uuid:980f7767-f49c-4268-9985-32002982a058 Last-Save-Date: 2022-04-08T08:30:04Z pdf:docinfo:keywords: methylphenidate, attention deficit/hyperactivity disorder (ADHD), striatum, single photon emission computed tomography (SPECT), responsivity, caudate nucleus, dopamine transporter (DAT) pdf:docinfo:modified: 2022-04-08T08:30:04Z meta:save-date: 2022-04-08T08:30:04Z Content-Type: application/pdf X-Parsed-By: org.apache.tika.parser.DefaultParser creator: Hans-Christoph Aster and Lorenz Deserno dc:language: en dc:subject: methylphenidate, attention deficit/hyperactivity disorder (ADHD), striatum, single photon emission computed tomography (SPECT), responsivity, caudate nucleus, dopamine transporter (DAT) access_permission:assemble_document: true xmpTPg:NPages: 11 pdf:charsPerPage: 3453 access_permission:extract_content: true access_permission:can_print: true meta:keyword: methylphenidate, attention deficit/hyperactivity disorder (ADHD), striatum, single photon emission computed tomography (SPECT), responsivity, caudate nucleus, dopamine transporter (DAT) access_permission:can_modify: true pdf:docinfo:created: 2022-04-08T03:56:38Z